Expired
Lead Plaintiff Deadline
Jan 9, 2026
Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that Telix Pharmaceuticals Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) defendants materially overstated the progress Telix had made with regard to prostate cancer therapeutic candidates; (2) defendants materially overstated the quality of Telix’s supply chain and partners; and (3) as a result, defendants’ statements about Telix’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
In order to be eligible to join the TLX class action lawsuit, you must have incurred a loss on shares of Telix Pharmaceuticals Ltd. purchased during the class period listed above.
If you suffered a loss in Telix Pharmaceuticals Ltd. during the relevant time frame or pursuant to the relevant offering(s), you have until January 9, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP
